Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z1OS
|
||||
Former ID |
DNCL002833
|
||||
Drug Name |
ARI-2243
|
||||
Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Phase 1 | [548767] | ||
Company |
Arisaph Pharmaceuticals
|
||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Modulator | [544150] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.